TriangleNCT00265941 · OUTCOME
2-year Nodal Relapse Rates in Clinical N2-3 Patients by Post-treatment PET/CT Finding and Nodal Response
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- From randomization to 2 years
What was measured
Patients are grouped by the combination of clinical nodal response status and the post-treatment PET/CT finding (negative or positive). Nodal relapse rate is calculated for each group by the cumulative incidence method. Relapse is defined as reappearance of tumor after complete response. If possible, relapse should be confirmed by biopsy.
Analysis population: Randomized eligible N2-3 patients with follow-up and PET data
Groups in this outcome
Clinical CR + Negative PET
Clinical nodal complete response; negative post-treatment PET/CT scan
No Clinical CR + Negative PET
Did not have clinical nodal complete response; negative post-treatment PET/CT scan
Clinical CR + Positive PET
Clinical nodal complete response; positive post-treatment PET/CT scan
No Clinical CR + Positive PET
No clinical nodal complete response; positive post-treatment PET/CT scan
| Group | Source count |
|---|---|
| Clinical CR + Negative PET | 26 |
| No Clinical CR + Negative PET | 15 |
| Clinical CR + Positive PET | 12 |
| No Clinical CR + Positive PET | 9 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Clinical CR + Negative PET | 3.9 | Not reported | 0 | 11.4 | Not reported |
| No Clinical CR + Negative PET | 33.3 | Not reported | 8.4 | 58.3 | Not reported |
| Clinical CR + Positive PET | 16.7 | Not reported | 0 | 38.8 | Not reported |
| No Clinical CR + Positive PET | 11.1 | Not reported | 0 | 33.1 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0
- upper Limit
- 11.4
- value
- 3.9
- group Id
- OG001
- lower Limit
- 8.4
- upper Limit
- 58.3
- value
- 33.3
- group Id
- OG002
- lower Limit
- 0
- upper Limit
- 38.8
- value
- 16.7
- group Id
- OG003
- lower Limit
- 0
- upper Limit
- 33.1
- value
- 11.1
- denoms
- counts
- group Id
- OG000
- value
- 26
- group Id
- OG001
- value
- 15
- group Id
- OG002
- value
- 12
- group Id
- OG003
- value
- 9
- units
- Participants
- description
- Patients are grouped by the combination of clinical nodal response status and the post-treatment PET/CT finding (negative or positive). Nodal relapse rate is calculated for each group by the cumulative incidence method. Relapse is defined as reappearance of tumor after complete response. If possible, relapse should be confirmed by biopsy.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Clinical nodal complete response; negative post-treatment PET/CT scan
- id
- OG000
- title
- Clinical CR + Negative PET
- description
- Did not have clinical nodal complete response; negative post-treatment PET/CT scan
- id
- OG001
- title
- No Clinical CR + Negative PET
- description
- Clinical nodal complete response; positive post-treatment PET/CT scan
- id
- OG002
- title
- Clinical CR + Positive PET
- description
- No clinical nodal complete response; positive post-treatment PET/CT scan
- id
- OG003
- title
- No Clinical CR + Positive PET
- param Type
- NUMBER
- population Description
- Randomized eligible N2-3 patients with follow-up and PET data
- reporting Status
- POSTED
- time Frame
- From randomization to 2 years
- title
- 2-year Nodal Relapse Rates in Clinical N2-3 Patients by Post-treatment PET/CT Finding and Nodal Response
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice